Form 8947 at a glance
What it is: Form 8947 is the Report of Branded Prescription Drug Information of the Department of the Treasury - Internal Revenue Service.
Where and when to file: File Form 8947 by December 17, 2012, to report sales year 2011 information. Send Form 8947 to: Internal Revenue Service 1973 Rulon White Boulevard Mail Stop 4916 Ogden, UT 84404.
Generally, each manufacturer or importer of branded prescription drugs with sales to specified government programs (or sales due to coverage under the programs) may submit Form 8947.
Each entity that is treated as a single covered entity is requested to file one Form 8947, providing all requested information for each such manufacturing and reporting entity.
A filled-in Form 8947 example: a single-person covered entity fills out page 1

How to fill out Form 8947, box by box
Item B: Check one (see instructions)

Item B: Check one (see instructions). Check box 1 if you are a single-person covered entity. You must sign Part II on page 6.
Check box 2a if you are a common parent of an affiliated group. You must also sign Part II on page 6.
Check box 2b if you are the designated entity for a covered entity that is not an affiliated group. You must also sign Part II on page 6.
Generally, the designated entity is the common parent of an affiliated group or the member chosen to be the designated entity by the members of a controlled group that is not an affiliated group.
If you checked box 1, enter the name of the single-person covered entity. If you checked box 2a or 2b, enter the name of the designated entity.
Enter your P.O. box number only if your post office does not deliver mail to your street address.
Part I Controlled Group Members

If you checked box 2a or 2b, also complete Part I, Controlled Group Members, giving the name, address, and EIN of only those members of the controlled group who, as of the end of the day on December 31, 2011, are manufacturers or importers with gross receipts from the sale of branded prescription drugs to specified government programs (or sales due to coverage under the program). List the designated entity's name first.
Check if the entity was not listed on your report for sales year 2010.
Part II Signature of Official Signing On Behalf of the Covered Entity

Part II is the Signature of Official Signing On Behalf of the Covered Entity. Under penalties of perjury, you declare that you have examined this report, including accompanying statements, and, to the best of your knowledge and belief, it is true, correct, and complete.
If you checked Item B, box 2a or 2b, on page 1, you also declare that you identified as the common parent of an affiliated group or other designated entity.
If you checked Item B, box 2a or 2b, on page 1, you understand that the designated entity will receive IRS communications relating to the fee imposed by section 9008 of the Act and is to pay this fee to the IRS on behalf of the controlled group.
If you checked Item B, box 2a or 2b, on page 1, each entity that is a member of the controlled group is jointly and severally liable for this fee.
If you checked Item B, box 2a or 2b, on page 1, you further declare that each entity in the controlled group identified on this report consents to the choice of the designated entity indicated on this report.
Alternate Contact Person Designee (see instructions)
More rules for Form 8947
Use Form 8947 to report the following information for branded prescription drugs sold by covered entities to specified government programs (or sales due to coverage under the programs) during sales year 2011: National Drug Codes (NDCs), Medicaid state supplemental rebate information, section 45C orphan drug information, and designated entity and controlled group members information, if applicable.
United States postal regulations require forms and packages to be sent by First-Class Mail. However, you may use private delivery services such as DHL, Federal Express (FedEx), and United Parcel Service (UPS).
The schedules
Item A: Check one
All filers must complete page 1 and page 6, which includes Schedule E, Summary of Form 8947, and Part II, Signature of Official Signing On Behalf of the Covered Entity (Single-Member, Common Parent of an Affiliated Group, or Other Designated Entity) and Consent by the Common Parent or Designated Entity (if applicable).
Item A: Check one. Box 1 is for a first time filer: complete this page and page 6, and attach Schedule A, Branded Prescription Drug Information-First Time Filers Only.
In Item A, check box 2 if you are a subsequent year filer with changes: complete this page and page 6, and attach Schedule B, Branded Prescription Drug Information NDC Additions and Deletions, or Schedule C, Branded Prescription Drug Information Orphan Drug Changes-Previously Reported NDCs, or both.
In Item A, check box 3 if you are a subsequent year filer with no changes and reporting rebates; check box 4 if you are a subsequent year filer with no changes and not reporting rebates. Complete this page and page 6.
Subsequent year filers reporting Medicaid state supplemental rebates for sales year 2011 drug sales must attach Schedule D, Branded Prescription Drug Medicaid State Supplemental Rebates-Previously Reported NDCs, to report NDCs and their Medicaid state supplemental rebates.
Schedule A: first time filers only
Branded Prescription Drug Information - First Time Filers Only: if you filed Form 8947 for sales year 2010, do not use Schedule A for the 2011 sales year. Enter the 11-digit NDC (omitting hyphens) for any branded prescription drug sold to any specified government program (or sold due to coverage under the programs) during 2011.
Enter the Medicaid state supplemental rebates for each NDC paid by the covered entity for sales under Medicaid in sales year 2011, invoiced by states and paid before you file Form 8947.
Schedule B: NDC additions and deletions
If you filed Form 8947 for sales year 2010, use Schedule B (check Item A, box 2) to report the following for sales year 2011: NDCs that you did not report on your Form 8947 for sales year 2010 (additions), and NDCs that are no longer in the covered entity (deletions).
Use Schedule B only for additions and deletions of National Drug Codes (NDCs) at the covered entity level. Do not report the movement of NDCs between members of the controlled group.
(2) On Schedule B, Section I, report as additions only NDCs that were not associated with the covered entity for the previous sales year. (3) On Schedule B, Section II, Schedule C, or Schedule D, report only NDCs that were associated with the covered entity for the previous sales year.
Schedule C: orphan drug changes
If you filed Form 8947 for sales year 2010, use Schedule C (check Item A, box 2) to report changes in orphan drug information for previously reported NDCs. Do not include NDCs or orphan drug information reported on the Schedule B attached to this report.
Schedule D: Medicaid state supplemental rebates
If you filed Form 8947 for sales year 2010, use Schedule D (check Item A, box 2 or box 3, as applicable) to report Medicaid state supplemental rebates paid by the covered entity for sales under Medicaid occurring in sales year 2011. Enter rebates only for NDCs which you reported when you filed Form 8947 for sales year 2010.
Schedule E: Summary of Form 8947
Summary of Form 8947: use Schedule E to report the total number of controlled group members, including the designated entity, shown on page 1, Part I, and the totals from each of the other schedules attached to this report.
Schedule E, line 1: enter the total number of controlled group members, including the designated entity, from page 1, Part I.
Common questions about Form 8947
Is there a deadline?
File Form 8947 by December 17, 2012, to report sales year 2011 information.
Where do I file it?
Send Form 8947 to: Internal Revenue Service 1973 Rulon White Boulevard Mail Stop 4916 Ogden, UT 84404. Send the forms in a flat mailing (not folded). Do not staple, tear, or tape any of these forms.
Sources
[1] Form 8947 (Rev. October 2012), Department of the Treasury - Internal Revenue Service (the Official source link on this page).

